Low‐risk paediatric Crohn's disease: A narrative review of current evidence and unmet research needs
Journal of Pediatric Gastroenterology and Nutrition · 10.11.2026
DOI: 10.1002/jpn3.70652 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 10.11.2026. Verfasst von Saverio Pochesci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Gastroenterology and Digestive Endoscopy Unit - IRCCS Istituto Giannina Gaslini, Genova, Italy. Die Arbeit nennt 49 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
While current paediatric management increasingly favours early intensive treatment for children and adolescents with Crohn's disease (CD) at high risk of disease progression, a smaller subset of patients presents with a potentially ‘low‐risk’ disease phenotype. Identifying these children is clinically challenging, as overtreatment may expose them to unnecessary risks and costs, whereas undertreatment may allow irreversible bowel damage and complications to develop. This narrative review summarises the current evidence on the definition, assessment, treatment, and monitoring of low‐risk paediatric CD, highlighting existing knowledge gaps and future research priorities. At present, no consensus definition of low‐risk paediatric CD exists, and disease classification relies largely on the absence of recognised high‐risk features rather than validated criteria. Similarly, unlike adult practice, no paediatric prognostic model is available to identify children likely to follow a persistently mild disease course. Current assessment requires integration of clinical indices, inflammatory biomarkers, endoscopy, cross‐sectional imaging, and evaluation of growth and nutritional status. Dietary treatment (Exclusive Enteral Nutrition and emerging dietary strategies, including the CD Exclusion Diet [CDED] and the Tasty & Healthy [T&H]] remains the commonest induction therapy. Budesonide or antibiotics (azithromycin and metronidazole) represent an appropriate alternative for selected children. CDED and the T&H diet may also represent attractive medium term treatment options, although robust maintenance data are still awaited. Prospective studies are needed to establish a consensus definition, develop paediatric‐specific prediction models, optimise risk stratification, and determine the most effective long‐term therapeutic and monitoring approaches for the ‘low‐risk’ population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paediatric Gastroenterology and Digestive Endoscopy Unit - IRCCS Istituto Giannina Gaslini, Genova, Italy.
- Gastroenterology and Nutrition Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
- Department of Biomedical and Clinical Science, University of Milan, Milan, Italy.
- Pediatric Department, Vittore Buzzi Children's Hospital, Milan, Italy.
- Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK.
- Child Life and Health, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Saverio Pochesci, Luca Scarallo, Laura Gianolio, Richard K Russell
Förderung
- None
Zitieren
APA
Pochesci, S., Scarallo, L., Gianolio, L., & Russell, R. K. (2026). Low‐risk paediatric Crohn's disease: A narrative review of current evidence and unmet research needs. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70652
Vancouver
Pochesci S, Scarallo L, Gianolio L, Russell RK. Low‐risk paediatric Crohn's disease: A narrative review of current evidence and unmet research needs. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70652
BibTeX
@article{Pochesci2026,
author = {Pochesci, Saverio and Scarallo, Luca and Gianolio, Laura and Russell, Richard K},
title = {Low‐risk paediatric Crohn's disease: A narrative review of current evidence and unmet research needs},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70652}
}
EUVIMED